Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.55 |
| ▸ | KIF11 | P52732 | 5/20 | 0.50 |
| ▸ | AHR | P35869 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | CMA1 | P23946 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.43 |
| ▸ | MPO | P05164 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7088387 | 0.88 | S1PR1 (0.51) | ESR1KIF11AHRCMA1TYR | |
| SCHEMBL7084999 | 0.86 | NPC1 (0.62) | ESR1KIF11AHRNPC1EPHX2 | |
| SCHEMBL45243 | 0.85 | KIF11 (0.65) | ESR1KIF11AHRCMA1TYR | |
| SCHEMBL29355842 | 0.85 | KIF11 (0.65) | ESR1KIF11AHRCMA1TYR | |
| SCHEMBL10236267 | 0.82 | CHRNB4 (0.47) | KIF11AHRNPC1CMA1TYR | |
| SCHEMBL147946 | 0.79 | AHR (0.70) | ESR1AHRNPC1CMA1TYR | |
| SCHEMBL3860188 | 0.78 | GHSR (0.51) | AHRNPC1CMA1TYRCHRNB4 | |
| SCHEMBL29275206 | 0.78 | ESR1 (0.51) | ESR1KIF11AHRCMA1TYR | |
| SCHEMBL18000228 | 0.78 | BRAF (0.58) | AHRNPC1CMA1TYRCHRNB4 | |
| SCHEMBL13676215 | 0.78 | TRPV1 (0.45) | ESR1KIF11NPC1EPHX2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200275655-A1 | PYRIDINIUM SALT AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20030203959-A1 | Novel modulators of potassium channels | 4SC AG (DE) | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203959-A1 | Novel modulators of potassium channels | HCN3, KCNN3, KCNN1 | ESR1 2251/4885KIF11 3370/4885AHR 379/4885 |
| US-20200275655-A1 | PYRIDINIUM SALT AND PEST CONTROL AGENT | PRDX1, KCNQ5, KCNQ1 | ESR1 3109/4885KIF11 3339/4885AHR 1255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.